As Jp Morgan Chase & Co Com (JPM) Valuation Declined, Mader & Shannon Wealth Management Increased Holding by $2.00 Million; Alps Advisors Boosted Tesaro (TSRO) Holding by $722,532; Market Value Declined

June 14, 2018 - By Henry Gaston

JPMorgan Chase & Co. (NYSE:JPM) Logo

Alps Advisors Inc increased its stake in Tesaro Inc (TSRO) by 21.03% based on its latest 2018Q1 regulatory filing with the SEC. Alps Advisors Inc bought 12,676 shares as the company’s stock declined 13.40% with the market. The institutional investor held 72,938 shares of the health care company at the end of 2018Q1, valued at $4.17M, up from 60,262 at the end of the previous reported quarter. Alps Advisors Inc who had been investing in Tesaro Inc for a number of months, seems to be bullish on the $2.29B market cap company. The stock decreased 2.52% or $1.08 during the last trading session, reaching $41.77. About 1.16 million shares traded. Tesaro, Inc. (NASDAQ:TSRO) has declined 66.21% since June 14, 2017 and is downtrending. It has underperformed by 78.78% the S&P500. Some Historical TSRO News: 15/04/2018 – MERCK SAYS KEYTRUDA SAFETY PROFILE CONSISTENT W/ PRIOR TRIALS; 02/04/2018 – Aeglea BioTherapeutics Doses First Small Cell Lung Cancer Patients with Pegzilarginase in Both Monotherapy and KEYTRUDA® (Pemb; 17/05/2018 – Eisai Announces Data at ASCO 2018 Annual Meeting Showcasing LENVIMA® (lenvatinib) and KEYTRUDA® (pembrolizumab) Combination Therapy Under Strategic Oncology Collaboration with Merck; 23/03/2018 – CHMP GRANTS POSITIVE OPINION FOR CLOVIS ONCOLOGY’S RUBRACA® (RU; 03/04/2018 – AstraZeneca PLC Lynparza is Used for Patients With Metastatic Breast Cancer; 09/04/2018 – MERCK & CO INC – SAFETY PROFILE OF KEYTRUDA IN PHASE 3 TRIAL WAS CONSISTENT; 10/04/2018 – BerGenBio Completes Recruitment Into First Stage of Phase Il NSCLC Trial With Selective AXL Inhibitor Bemcentinib Combined With KEYTRUDA®; 10/04/2018 – Oncolytics Biotech: Combination Therapy With REOLYSIN(R), Keytruda(R) and/or anti-CD73 Immunotherapy Led to Rejection of Pre-Established Tumors; 23/03/2018 – CHMP GRANTS POSITIVE OPINION FOR CLOVIS ONCOLOGY’S RUBRACA®; 08/05/2018 – MERCK – EMA APPROVED LYNPARZA TABLETS (300 MG TWICE DAILY) FOR USE AS A MAINTENANCE THERAPY WITH PLATINUM-SENSITIVE RELAPSED OVARIAN CANCER

Mader & Shannon Wealth Management Inc increased its stake in Jp Morgan Chase & Co Com (JPM) by 105.73% based on its latest 2018Q1 regulatory filing with the SEC. Mader & Shannon Wealth Management Inc bought 18,373 shares as the company’s stock declined 6.83% with the market. The institutional investor held 35,751 shares of the major banks company at the end of 2018Q1, valued at $3.93 million, up from 17,378 at the end of the previous reported quarter. Mader & Shannon Wealth Management Inc who had been investing in Jp Morgan Chase & Co Com for a number of months, seems to be bullish on the $368.98B market cap company. The stock decreased 1.44% or $1.58 during the last trading session, reaching $108.39. About 11.89M shares traded. JPMorgan Chase & Co. (NYSE:JPM) has risen 29.65% since June 14, 2017 and is uptrending. It has outperformed by 17.08% the S&P500. Some Historical JPM News: 30/04/2018 – INDONESIA FINANCE MINISTRY’S DEBT OFFICE COMMENTS ON JPMORGAN; 07/03/2018 – Air Products’ CEO to Speak at J.P. Morgan Aviation, Transportation and Industrials Conference on March 14; 23/03/2018 – MOVES-UBS Wealth Management lands mega-group from JPMorgan’s private bank; 18/04/2018 – JPMorgan mulls moving 200 bankers to Paris post-Brexit -Les Echos; 30/05/2018 – ACTIVE TREASURIES CLIENTS SHOW MOST NET LONGS SINCE MARCH 6, 2017 – J.P. MORGAN SURVEY; 05/03/2018 – StarBusinessClub: Amazon in talks with JPMorgan, Capital One over chequing accounts; 15/05/2018 – JPMorgan’s Farrell Sees China Committed to Opening Up: TOPLive; 24/04/2018 – ALFA LAVAL AB ALFA.ST : JP MORGAN RAISES TARGET PRICE TO SEK 210 FROM SEK 201; 18/04/2018 – JPMorgan Asset Management seeks China A-share research edge; 21/03/2018 – JPMorgan CEO Jamie Dimon Makes 364 Times Typical Worker — MarketWatch

More recent Tesaro, Inc. (NASDAQ:TSRO) news were published by: Seekingalpha.com which released: “Tesaro: Can Upcoming Catalyst Bring Fortune To This Unpopular Company?” on June 01, 2018. Also Seekingalpha.com published the news titled: “Reader Inquiry: Has Tesaro Finally Found A Bottom?” on May 23, 2018. Investorplace.com‘s news article titled: “5 Top Stock Trades for Thursday Morning” with publication date: May 30, 2018 was also an interesting one.

Investors sentiment increased to 1.14 in Q1 2018. Its up 0.13, from 1.01 in 2017Q4. It increased, as 41 investors sold TSRO shares while 58 reduced holdings. 33 funds opened positions while 80 raised stakes. 60.57 million shares or 4.53% more from 57.95 million shares in 2017Q4 were reported. Metropolitan Life Ins Ny has 2,773 shares. Stifel Finance has invested 0% in Tesaro, Inc. (NASDAQ:TSRO). Global X Mgmt Llc stated it has 0% of its portfolio in Tesaro, Inc. (NASDAQ:TSRO). Sg Americas Limited Liability Corporation invested 0% in Tesaro, Inc. (NASDAQ:TSRO). Alyeska Inv Group Incorporated Lp invested in 172,353 shares or 0.09% of the stock. Goldman Sachs Group holds 0.01% of its portfolio in Tesaro, Inc. (NASDAQ:TSRO) for 414,574 shares. Moreover, Gateway Advisers Ltd Liability Com has 0.01% invested in Tesaro, Inc. (NASDAQ:TSRO). State Street Corporation holds 0.01% of its portfolio in Tesaro, Inc. (NASDAQ:TSRO) for 1.76 million shares. Axa holds 144,691 shares or 0.03% of its portfolio. Moreover, Deutsche State Bank Ag has 0.02% invested in Tesaro, Inc. (NASDAQ:TSRO) for 662,100 shares. Bailard Inc has invested 0.03% in Tesaro, Inc. (NASDAQ:TSRO). Asset Incorporated reported 2,193 shares. Morgan Stanley has 0% invested in Tesaro, Inc. (NASDAQ:TSRO) for 311,690 shares. 69,173 are held by Citadel Advisors Ltd Liability Corp. Asset Mgmt One Ltd has invested 0.01% in Tesaro, Inc. (NASDAQ:TSRO).

Since March 1, 2018, it had 9 buys, and 7 selling transactions for $61.19 million activity. $141,265 worth of Tesaro, Inc. (NASDAQ:TSRO) was sold by PEARSON TIMOTHY R. $144,501 worth of Tesaro, Inc. (NASDAQ:TSRO) was sold by Farmer Joseph L on Thursday, March 1. $6.68M worth of Tesaro, Inc. (NASDAQ:TSRO) shares were bought by NEW ENTERPRISE ASSOCIATES 13 LP. Shares for $8.35M were bought by SANDELL SCOTT D. Another trade for 145,532 shares valued at $8.35M was made by MOTT DAVID M on Friday, March 2. Shares for $18,488 were sold by Oliveira Orlando.

Alps Advisors Inc, which manages about $13.32B and $12.57B US Long portfolio, decreased its stake in Abiomed Inc (NASDAQ:ABMD) by 1,406 shares to 2,796 shares, valued at $814,000 in 2018Q1, according to the filing. It also reduced its holding in Vanguard Ftse Emerging Markets (VWO) by 81,780 shares in the quarter, leaving it with 1.24M shares, and cut its stake in Energy Transfer Partners Lp.

Among 25 analysts covering Tesaro Inc (NASDAQ:TSRO), 15 have Buy rating, 1 Sell and 9 Hold. Therefore 60% are positive. Tesaro Inc had 81 analyst reports since August 24, 2015 according to SRatingsIntel. The company was initiated on Monday, August 24 by Leerink Swann. Jefferies maintained the stock with “Hold” rating in Monday, September 25 report. FBR Capital maintained it with “Hold” rating and $19500 target in Monday, June 5 report. The firm earned “Buy” rating on Tuesday, March 27 by Wedbush. The company was maintained on Friday, August 5 by Wedbush. As per Tuesday, July 19, the company rating was initiated by Robert W. Baird. As per Friday, November 4, the company rating was downgraded by Raymond James. Raymond James initiated the shares of TSRO in report on Tuesday, September 1 with “Strong-Buy” rating. As per Wednesday, February 28, the company rating was maintained by Leerink Swann. The rating was maintained by Mizuho on Friday, August 5 with “Buy”.

Mader & Shannon Wealth Management Inc, which manages about $143.46 million and $84.24M US Long portfolio, decreased its stake in Vanguard Index Funds S&P 500 Etf (VOO) by 4,603 shares to 135,332 shares, valued at $32.76M in 2018Q1, according to the filing.

Since January 13, 2018, it had 3 insider purchases, and 8 selling transactions for $18.63 million activity. Shares for $2.00M were bought by HOBSON MELLODY L. Another trade for 7,280 shares valued at $825,327 was bought by CROWN JAMES S. On Saturday, January 13 the insider Erdoes Mary E. sold $7.31M. Another trade for 16,434 shares valued at $1.84 million was sold by BACON ASHLEY. The insider Lake Marianne sold $1.03 million. 3,783 shares were sold by Giles Nicole, worth $425,399 on Saturday, January 13.

Among 34 analysts covering JPMorgan Chase & Co (NYSE:JPM), 18 have Buy rating, 2 Sell and 14 Hold. Therefore 53% are positive. JPMorgan Chase & Co had 120 analyst reports since July 21, 2015 according to SRatingsIntel. RBC Capital Markets maintained JPMorgan Chase & Co. (NYSE:JPM) rating on Thursday, June 15. RBC Capital Markets has “Buy” rating and $9500 target. The firm has “Neutral” rating given on Friday, September 9 by Macquarie Research. Berenberg initiated the shares of JPM in report on Wednesday, July 13 with “Sell” rating. Atlantic Securities upgraded JPMorgan Chase & Co. (NYSE:JPM) on Friday, January 15 to “Overweight” rating. Morgan Stanley maintained JPMorgan Chase & Co. (NYSE:JPM) on Monday, April 30 with “Overweight” rating. Robert W. Baird maintained JPMorgan Chase & Co. (NYSE:JPM) rating on Wednesday, September 20. Robert W. Baird has “Hold” rating and $88.0 target. On Friday, January 12 the stock rating was maintained by RBC Capital Markets with “Buy”. As per Tuesday, September 26, the company rating was maintained by RBC Capital Markets. UBS reinitiated it with “Buy” rating and $98 target in Wednesday, January 11 report. The stock of JPMorgan Chase & Co. (NYSE:JPM) has “Buy” rating given on Friday, August 18 by RBC Capital Markets.

JPMorgan Chase & Co. (NYSE:JPM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Henry Gaston

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:








Recent Posts